Skip to main content
See every side of every news story
Get Started
SubscribeLogin
Published • loading... • Updated

Leerink Partnrs Has Negative Outlook of HALO FY2025 Earnings

Summary by themarketsdaily.com
Halozyme Therapeutics, Inc. (NASDAQ:HALO – Free Report) – Stock analysts at Leerink Partnrs lowered their FY2025 earnings per share (EPS) estimates for Halozyme Therapeutics in a research note issued to investors on Wednesday, October 1st. Leerink Partnrs analyst D. Risinger now anticipates that the biopharmaceutical company will post earnings of $5.72 per share for the […]
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

1 Articles

themarketsdaily.comthemarketsdaily.com

Leerink Partnrs Has Negative Outlook of HALO FY2025 Earnings

Halozyme Therapeutics, Inc. (NASDAQ:HALO – Free Report) – Stock analysts at Leerink Partnrs lowered their FY2025 earnings per share (EPS) estimates for Halozyme Therapeutics in a research note issued to investors on Wednesday, October 1st. Leerink Partnrs analyst D. Risinger now anticipates that the biopharmaceutical company will post earnings of $5.72 per share for the […]

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.

Factuality 

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

themarketsdaily.com broke the news in on Wednesday, October 8, 2025.
Sources are mostly out of (0)
Stories disproportionately reported by the Left or the Right

Similar News Topics

San Diego icon

San Diego

News
For You
SearchBlindspotLocal